Percutaneous penetration of topically applied melatonin in a cream and an alcoholic solution

Skin Pharmacology and Physiology

Volumn 17, Issue 4, 2004, Pages 190-194

  Fischer, T W ^a   Greif, C ^a   Fluhr, J W ^a   Wigger Alberti, W ^a   Elsner, P ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Melatonin; Penetration, percutaneous; Serum levels; Topical application

Indexed keywords

ALCOHOL; MELATONIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG PENETRATION; FEMALE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SKIN PENETRATION;

ADMINISTRATION, CUTANEOUS; ADULT; CIRCADIAN RHYTHM; ETHANOL; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; OINTMENTS; SKIN; SKIN ABSORPTION; SOLUTIONS; TIME FACTORS;

EID: 3242760802     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078822     Document Type: Article

References (20)

1. Arendt J: The pineal; in Touitou Y, Haus E (eds): Biological Rhythms in Clinical and Laboratory Medicine. Berlin, Springer, 1992, pp 348-362.
2. Webb SM, Puig-Domingo M: Role of melatonin in health and disease. Clin Endocrinol (Oxf) 1995;42:221-234.
3. Lane EA, Moss HB: Pharmacokinetics of melatonin in man: First pass hepatic metabolism. J Clin Endocrinol Metab 1985;61:1214-1216.
4. Waldhauser F, Waldhauser M, Liebermann HR, Deng MH, Lynch HR, Wurtman RJ: Bioavailability of oral melatonin in humans. Neuroendocrinology 1984;39:307-314.
5. Mastreoni JM, Conti A, Pierpaoli W: Melatonin stress and the immune system. Pineal Res Rev 1989;7:203-226.
6. Poeggeler B, Saarela S, Reiter RJ, Tan DX, Chen LD, Manchester LC, Barlow-Walden LR: Melatonin - a highly potent endogenous radical scavenger and electron donor: New aspects of the oxidation chemistry of this indole accessed in vitro. Ann NY Acad Sci 1994;738: 419-420.
7. Reiter RJ, Poeggeler B, Tan DX, Chen LD, Manchester LC, Guerrero JM: Antioxidant capacity of melatonin: A novel action not requiring a receptor. Neuroendocrinol Lett 1993;15: 103-116.
8. Steinhilber D: Melatonin. Wunderhormon oder Verbindung ohne therapeutischen Wert? Dtsch Apoth Ztg 1996;136:1647-1654.
9. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ: Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocr J 1993;1:57-60.
10. Bangha E, Elsner P, Kistler GS: Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). A dose response study. Arch Dermatol Res 1996;288:522-526.
11. Fischer T, Bangha E, Elsner P, Kistler GS: Suppression of UV-induced erythema by topical treatment with melatonin. Influence of the application time point. Biol Signals Recept 1999; 8:132-135.
12. Dreher F, Gabard B, Schwindt DA, Maibach HI: Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema: A human study in vivo. Br J Dermatol 1998;139:332-339.
13. Lee BJ, Parrott KA, Ayres JW, Sack RL: Preliminary evaluation of transdermal delivery of melatonin in human subjects. Res Commun Mol Pathol Pharmacol 1994;85:337-346.
14. Mallo C, Zaidan R, Galy G, Vermeulen E, Brun J, Chazot G, Claustrat B: Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection. Eur J Clin Pharmacol 1990;38:297-301.
15. Schwarz W, Birau N, Hornstein OP, Heubeck B, Schönberger A, Meyer C, Gottschalk J: Alterations of melatonin secretion in atopic eczema. Acta Derm Venereol 1988;68:224-229.
16. Bangha E, Lauth D, Kistler GS, Elsner P: Daytime serum levels of melatonin after topical application onto the human skin. Skin Pharmacol 1997;10:298-302.
17. Kikwai L, Kanikkannan N, Babu RJ, Singh M: Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro. J Control Release 2002;83:307-311.
18. Kandimalla K, Kanikkannan N, Andega S, Singh M: Effect of fatty acids on the permeation of melatonin across rat and pig skin invitro and on the transepidermal water loss in rats in-vivo. J Pharm Pharmacol 1999;51:783-790.
19. Oh HJ, Oh YK, Kim CK: Effects of vehicles and enhancers on transdermal delivery of melatonin. Int J Pharm 2001;212:63-71.
20. Benes L, Claustrat B, Horriere F, Geoffriau M, Konsil J, Parrott KA, DeGrande G, McQuinn RL, Ayres JW: Transmucosal, oral controlledrelease, and transdermal drug administration in human subjects: A crossover study with melatonin. J Pharm Sci 1997;86:1115-1119.